| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |